Literature DB >> 6144572

Solubilization in high yield of opioid receptors retaining high-affinity delta, mu and kappa binding sites.

C D Demoliou-Mason, E A Barnard.   

Abstract

The binding sites for opiates (agonist and antagonist) and opioid peptides can be solubilized from rat brain membranes with digitonin in the presence of Mg2+ (10 mM). High affinity and high capacity binding to the soluble delta, mu, and kappa receptors is obtainable when the membranes are treated in Mg2+ (30 degrees C, 60 min) prior to solubilization. The yields of solubilized binding sites extracted with digitonin, 40-90%, are higher than those obtained from Mg2+-pretreated membranes with other detergents commonly used for receptor solubilization. The stability of the digitonin-soluble opioid receptor at room temperature makes it useful for purification and characterization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144572     DOI: 10.1016/0014-5793(84)81348-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Changes in opioid receptor proteins during mitochondrial impairment in differentiated SK-N-SH cells.

Authors:  Atul Raut; Vidhya R Rao; Anna Ratka
Journal:  Neurosci Lett       Date:  2007-06-17       Impact factor: 3.046

2.  Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors.

Authors:  R S Zukin; M Eghbali; D Olive; E M Unterwald; A Tempel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Solubilization and purification of the retinol-binding protein receptor from human placental membranes.

Authors:  A Sivaprasadarao; M Boudjelal; J B Findlay
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

4.  Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: Finding novel anti-fibrotic therapies.

Authors:  Zhenping Chen; Jianhua Gu; Amina El Ayadi; Andres F Oberhauser; Jia Zhou; Linda E Sousse; Celeste C Finnerty; David N Herndon; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2018-09-22       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.